Osimertinib Drug Interactions

Brand name
  • Tagrisso
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

About Osimertinib

Osimertinib is a kinase inhibitor used to treat certain types of non-small-cell lung cancer that has spread or to prevent it from returning after surgery.

Read the full Osimertinib drug information page 

The Bottom Line on Osimertinib

Ondansetron is the pairing to know about first: taken alongside osimertinib, it can raise the risk of a heart rhythm change called QT prolongation. Hydroxyzine, another medicine many people take, is rated major for the same reason.

Osimertinib is a daily tablet that treats certain lung cancers that have spread, and helps keep them from coming back after surgery. It has more documented interactions than most medicines, and most of them are rated major or contraindicated. Heart effects are the problem that turns up most often, followed by changes in how much medicine is in the blood and medicines that work less well.

Because the list is long, tell every prescriber, a dentist or an urgent care clinic included, that you take osimertinib before anything new is started.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Osimertinib Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented osimertinib interaction, supplements and herbs included.

    What Could Happen When Osimertinib Interacts

    What the 348 documented osimertinib interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site. One interaction can name more than one problem, so the numbers add up to more than 348.

    Osimertinib Interactions by Severity

    Contraindicated

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Osimertinib meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Osimertinib?

    Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Osimertinib’s Interactions

    The 181 sources our osimertinib interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2024. DailyMed 
    2. Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2024. DailyMed 
    3. Planchard D, Janne PA, Cheng Y, et al: Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med 2023; 389(21):1935-1948.
    4. Product Information: TAGRISSO® oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP, Wilmington, DE, 2026. DailyMed 
    5. Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2024. DailyMed 
    6. Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2020. DailyMed 
    7. Wu Y-L, Tsuboi M, He J, et al: Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med 2020; 383(18):1711-1723.
    8. Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per manufacturer), Wilmington, DE, 2018. DailyMed 
    9. Soria JC, Ohe Y, Vansteenkiste J, et al: Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 2018; 378(2):113-125.
    10. Ramalingam SS, Vansteenkiste J, Planchard D, et al: Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med 2020; 382(1):41-50.

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.